HoxB4 Activators
HoxB4 Activators comprise a range of compounds that indirectly enhance the activity of HoxB4, a crucial transcription factor involved in embryonic development and cellular differentiation. These activators influence various signaling pathways and epigenetic mechanisms that regulate the expression and function of HoxB4. Retinoic Acid, all trans and Cholecalciferol modulate retinoic acid and vitamin D receptor pathways, respectively, both of which are known to affect the regulation of homeobox genes, including HoxB4. This modulation enhances HoxB4's role in guiding developmental processes. Similarly, 5-Azacytidine and Trichostatin A, acting as a DNA methyltransferase inhibitor and a histone deacetylase inhibitor, respectively, induce epigenetic changes that can lead to increased expression of HoxB4. These changes in DNA methylation and chromatin structure provide a conducive environment for the upregulation of HoxB4, thus influencing cellular differentiation and development.
In addition to epigenetic modulators, compounds like Lithium chloride target signaling pathways such as Wnt/β-catenin, a pathway closely linked with the regulation of Hox genes. By modulating this pathway, these compounds indirectly influence HoxB4 activity, highlighting its role in development. Other activators like RA-9, Valproic acid, Forskolin, ICG-001, 3-Deazaneplanocin, HCl salt, and Sodium butyrate further contribute to the regulation of HoxB4 through diverse mechanisms. These include modulation of histone acetylation, elevation of cAMP levels, antagonism of Wnt signaling, reduction of histone methylation, and alteration of chromatin remodeling. Together, these mechanisms underline the complexity of HoxB4 regulation and underscore the intricate network of signaling and epigenetic modifications that govern its activity. By influencing these pathways, HoxB4 Activators play a pivotal role in guiding the processes of embryogenesis and cellular differentiation, reflecting the multifaceted nature of HoxB4's function in development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, all trans indirectly enhances HoxB4 activity by modulating retinoic acid signaling pathways, which influence the expression and function of Hox genes, including HoxB4, in developmental processes. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol indirectly activates HoxB4 by influencing the vitamin D receptor pathway, which plays a role in the regulation of homeobox genes, thereby potentially enhancing HoxB4's function in cellular differentiation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, indirectly enhances HoxB4 activity by promoting DNA demethylation, which can lead to the upregulation of Hox gene expression, including that of HoxB4. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, indirectly activates HoxB4 by altering chromatin structure, potentially leading to increased expression of Hox genes including HoxB4. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride, a Wnt signaling pathway modulator, indirectly enhances HoxB4 activity by influencing Wnt/β-catenin signaling, which can impact the expression of Hox genes, including HoxB4. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, a histone deacetylase inhibitor, indirectly activates HoxB4 by modifying chromatin structure, potentially leading to the upregulation of Hox genes including HoxB4. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an activator of adenylate cyclase, indirectly enhances HoxB4 activity by elevating cAMP levels, which can influence signaling pathways affecting Hox gene expression, including HoxB4. | ||||||
3-Deazaneplanocin, HCl salt | 120964-45-6 | sc-351856 sc-351856A sc-351856B | 1 mg 5 mg 10 mg | $256.00 $612.00 $936.00 | 2 | |
3-Deazaneplanocin, HCl salt, an EZH2 inhibitor, indirectly activates HoxB4 by reducing histone methylation, potentially leading to increased expression of Hox genes, including HoxB4, involved in development and differentiation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a histone deacetylase inhibitor, indirectly enhances HoxB4 activity by affecting chromatin remodeling, potentially leading to increased Hox gene expression including HoxB4. | ||||||